Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.7B | 5.5B | 6.2B | 5.4B |
Cost of revenue | 3.9B | 3.1B | 3.7B | 3.2B |
Gross profit | 2.8B | 2.4B | 2.5B | 2.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 1.5B | 1.1B | 1.2B | 906M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 510M | 468M | 496M | 483M |
Other income expense | 51M | 66M | 60M | 71M |
Pretax income | 1.1B | 696M | 757M | 494M |
Tax provision | 170M | 49M | 50M | 46M |
Net income | 908M | 647M | 707M | 448M |
Basic EPS | 0.9 | 0.6 | 0.7 | 0.5 |
Diluted EPS | 0.9 | 0.6 | 0.7 | 0.5 |
Basic average shares | 1.0B | 1.0B | 1.0B | 995.6M |
Diluted average shares | 1.0B | 1.0B | 1.0B | 995.6M |
EBITDA | 2.5B | 2.1B | 2.2B | 1.9B |
Net income from continuing op. | 908M | 647M | 707M | 448M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |